PaySign (PAYS) News & Sentiment

Paysign, Inc. is a small healthcare-focused Fintech company excelling in the $500M Patient Affordability market, with 230% revenue growth in its Pharma segment over the past four quarters. Despite a 40% stock decline in six months, Paysign's strong fundamentals and innovative solutions present a compelling investment opportunity with a fair value estimate of $3.33 per share. Paysign's strategic focus on Plasma and Patient Affordability programs, vertical integration, and innovation has driven significant growth and improved margins, funded entirely through organic cash flow.

Paysign is a promising microcap payment processing company with a projected 42% annualized return, potentially reaching $19/share by 2030 from $3.30/share today. The company excels in two primary sectors: plasma payment processing and pharma patient affordability, both offering significant growth and high gross margins. PAYS's plasma business boasts a 40% market share with steady 10-15% annual growth, while the pharma segment is expected to surpass plasma with rapid expansion.

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign to Host Third Quarter 2024 Earnings Call.

Here is how Paysign, Inc. (PAYS) and Recruit Holdings Co., Ltd. (RCRRF) have performed compared to their sector so far this year.

Niche Focus: Paysign specializes in healthcare payment solutions, primarily in plasma donor compensation and patient affordability programs. Revenue Growth: Significant growth in the patient affordability segment is now a substantial part of total revenue. Financial Resilience: The company has shown strong revenue and margin recovery post-pandemic, with promising future growth.

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Participate in the 2024 Maxim Fintech Virtual Symposium, June 25.

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced their participation in the iAccess Alpha Buyside Best Ideas Summer Conference, June 25-26, 2024. Jeff Baker, Paysign's Chief Financial Officer, will deliver a presentation at 2:30 p.m. EDT on June 25, and is available to host one-on-one meetings the following day, Ju.

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Participate in the June 2024 Sidoti Small-Cap Virtual Investor Conference.

PaySign continues to experience double-digit net sales growth driven by investments in prepaid card-based payment solutions for the plasma donation industry. The company has a strong presence with 465 plasma centers and 6.4 million cardholders, as well as sponsorship from large banks and card companies. The recent acquisition of shares by PaySign may lead to increased demand for the stock and lower cost of capital.